G, C., CW, C., RF, S., S, R., & KJ, Y. (2025). Impact of PlGF immunoassay imprecision on preeclampsia risk assessment with the sFlt-1 to PlGF ratio. American journal of clinical pathology, 164(2), 200. https://doi.org/10.1093/ajcp/aqaf032
Chicago Style (17th ed.) CitationG, Chen, Chan CW, Schaefer RF, Rana S, and Yeo KJ. "Impact of PlGF Immunoassay Imprecision on Preeclampsia Risk Assessment with the SFlt-1 to PlGF Ratio." American Journal of Clinical Pathology 164, no. 2 (2025): 200. https://doi.org/10.1093/ajcp/aqaf032.
MLA (9th ed.) CitationG, Chen, et al. "Impact of PlGF Immunoassay Imprecision on Preeclampsia Risk Assessment with the SFlt-1 to PlGF Ratio." American Journal of Clinical Pathology, vol. 164, no. 2, 2025, p. 200, https://doi.org/10.1093/ajcp/aqaf032.